Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.49 Million USD | 4.38% |
| 2022 | 3.26 Million USD | 37.07% |
| 2021 | 2.38 Million USD | 99.33% |
| 2020 | 1.19 Million USD | 32.34% |
| 2019 | 903 Thousand USD | -40.44% |
| 2018 | 1.51 Million USD | -46.53% |
| 2017 | 2.83 Million USD | -27.9% |
| 2016 | 3.93 Million USD | -37.55% |
| 2015 | 6.29 Million USD | -26.8% |
| 2014 | 8.6 Million USD | 19.89% |
| 2013 | 7.17 Million USD | -5.28% |
| 2012 | 7.57 Million USD | -26.27% |
| 2011 | 10.27 Million USD | 106.06% |
| 2010 | 4.98 Million USD | 46.19% |
| 2009 | 3.41 Million USD | -22.22% |
| 2008 | 4.38 Million USD | -0.07% |
| 2007 | 4.38 Million USD | -0.41% |
| 2006 | 4.4 Million USD | 203.79% |
| 2005 | 1.45 Million USD | -84.53% |
| 2004 | 9.37 Million USD | 34.03% |
| 2003 | 6.99 Million USD | -31.85% |
| 2002 | 10.26 Million USD | 34.5% |
| 2001 | 7.62 Million USD | -26.62% |
| 2000 | 10.39 Million USD | 19.49% |
| 1999 | 8.7 Million USD | 12.99% |
| 1998 | 7.7 Million USD | 6.94% |
| 1997 | 7.2 Million USD | 89.47% |
| 1996 | 3.8 Million USD | 92.89% |
| 1995 | 1.97 Million USD | 45.93% |
| 1994 | 1.35 Million USD | 8.87% |
| 1993 | 1.24 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 631 Thousand USD | 92.65% |
| 2024 Q1 | 340 Thousand USD | -29.01% |
| 2023 Q3 | 619 Thousand USD | -59.17% |
| 2023 FY | 3.4 Million USD | 4.38% |
| 2023 Q1 | 856 Thousand USD | -1.5% |
| 2023 Q4 | 478.94 Thousand USD | -22.63% |
| 2023 Q2 | 1.51 Million USD | 77.1% |
| 2022 FY | 3.26 Million USD | 37.07% |
| 2022 Q3 | 1.22 Million USD | 70.18% |
| 2022 Q2 | 721 Thousand USD | 61.3% |
| 2022 Q1 | 447 Thousand USD | -6.09% |
| 2022 Q4 | 869 Thousand USD | -29.18% |
| 2021 Q3 | 464 Thousand USD | -17.58% |
| 2021 Q1 | 823 Thousand USD | 120.64% |
| 2021 Q2 | 563 Thousand USD | -31.59% |
| 2021 Q4 | 476 Thousand USD | 2.59% |
| 2021 FY | 2.38 Million USD | 99.33% |
| 2020 Q1 | 242 Thousand USD | 36.72% |
| 2020 Q4 | 373 Thousand USD | 71.1% |
| 2020 Q2 | 363 Thousand USD | 50.0% |
| 2020 Q3 | 218 Thousand USD | -39.94% |
| 2020 FY | 1.19 Million USD | 32.34% |
| 2019 Q1 | 274 Thousand USD | -32.35% |
| 2019 Q3 | 189 Thousand USD | -28.14% |
| 2019 Q4 | 177 Thousand USD | -6.35% |
| 2019 Q2 | 263 Thousand USD | -4.01% |
| 2019 FY | 903 Thousand USD | -40.44% |
| 2018 Q1 | 377 Thousand USD | -25.05% |
| 2018 Q4 | 405 Thousand USD | 71.61% |
| 2018 FY | 1.51 Million USD | -46.53% |
| 2018 Q2 | 498 Thousand USD | 32.1% |
| 2018 Q3 | 236 Thousand USD | -52.61% |
| 2017 Q4 | 503 Thousand USD | -60.55% |
| 2017 FY | 2.83 Million USD | -27.9% |
| 2017 Q1 | 519 Thousand USD | -43.89% |
| 2017 Q2 | 538 Thousand USD | 3.66% |
| 2017 Q3 | 1.27 Million USD | 136.99% |
| 2016 FY | 3.93 Million USD | -37.55% |
| 2016 Q1 | 1.32 Million USD | -26.49% |
| 2016 Q3 | 689 Thousand USD | -30.68% |
| 2016 Q4 | 925 Thousand USD | 34.25% |
| 2016 Q2 | 994 Thousand USD | -24.92% |
| 2015 Q1 | 1.5 Million USD | -30.38% |
| 2015 FY | 6.29 Million USD | -26.8% |
| 2015 Q2 | 1.5 Million USD | -0.07% |
| 2015 Q3 | 1.71 Million USD | 13.47% |
| 2015 Q4 | 1.8 Million USD | 5.32% |
| 2014 FY | 8.6 Million USD | 19.89% |
| 2014 Q2 | 1.96 Million USD | -2.96% |
| 2014 Q1 | 2.02 Million USD | 32.38% |
| 2014 Q3 | 2.43 Million USD | 23.93% |
| 2014 Q4 | 2.16 Million USD | -11.19% |
| 2013 FY | 7.17 Million USD | -5.28% |
| 2013 Q4 | 1.53 Million USD | -8.1% |
| 2013 Q3 | 1.66 Million USD | -14.95% |
| 2013 Q2 | 1.96 Million USD | -2.78% |
| 2013 Q1 | 2.01 Million USD | -8.03% |
| 2012 Q1 | 1.71 Million USD | -53.64% |
| 2012 Q4 | 2.19 Million USD | 32.77% |
| 2012 Q3 | 1.65 Million USD | -18.15% |
| 2012 Q2 | 2.01 Million USD | 17.68% |
| 2012 FY | 7.57 Million USD | -26.27% |
| 2011 Q4 | 3.69 Million USD | 0.74% |
| 2011 Q2 | 1.39 Million USD | -7.23% |
| 2011 FY | 10.27 Million USD | 106.06% |
| 2011 Q3 | 3.67 Million USD | 162.52% |
| 2011 Q1 | 1.5 Million USD | 3.93% |
| 2010 Q3 | 1.28 Million USD | -4.12% |
| 2010 Q1 | 1.01 Million USD | -4.8% |
| 2010 FY | 4.98 Million USD | 46.19% |
| 2010 Q2 | 1.33 Million USD | 32.15% |
| 2010 Q4 | 1.45 Million USD | 13.19% |
| 2009 Q4 | 1.06 Million USD | 32.75% |
| 2009 FY | 3.41 Million USD | -22.22% |
| 2009 Q2 | 764 Thousand USD | -2.43% |
| 2009 Q3 | 800 Thousand USD | 4.71% |
| 2009 Q1 | 783 Thousand USD | -9.48% |
| 2008 Q2 | 1.18 Million USD | 29.33% |
| 2008 Q1 | 917 Thousand USD | -86.93% |
| 2008 FY | 4.38 Million USD | -0.07% |
| 2008 Q4 | 865 Thousand USD | -38.96% |
| 2008 Q3 | 1.41 Million USD | 19.48% |
| 2007 FY | 4.38 Million USD | -0.41% |
| 2007 Q4 | 7.01 Million USD | 533.6% |
| 2007 Q3 | 1.1 Million USD | -89.15% |
| 2007 Q2 | 10.2 Million USD | 1313.02% |
| 2007 Q1 | 722 Thousand USD | -28.3% |
| 2006 Q3 | 1.11 Million USD | -14.85% |
| 2006 Q4 | 1 Million USD | -9.44% |
| 2006 Q2 | 1.3 Million USD | 33.27% |
| 2006 FY | 4.4 Million USD | 203.79% |
| 2006 Q1 | 980 Thousand USD | 156.39% |
| 2005 FY | 1.45 Million USD | -84.53% |
| 2005 Q1 | 1.17 Million USD | -74.15% |
| 2005 Q2 | 1.15 Million USD | -1.95% |
| 2005 Q3 | 869 Thousand USD | -24.7% |
| 2005 Q4 | -1.73 Million USD | -300.0% |
| 2004 FY | 9.37 Million USD | 34.03% |
| 2004 Q1 | 1.42 Million USD | -4.29% |
| 2004 Q2 | 1.76 Million USD | 23.76% |
| 2004 Q3 | 1.62 Million USD | -7.93% |
| 2004 Q4 | 4.55 Million USD | 180.07% |
| 2003 Q1 | 1.69 Million USD | -2.42% |
| 2003 FY | 6.99 Million USD | -31.85% |
| 2003 Q4 | 1.49 Million USD | -18.84% |
| 2003 Q3 | 1.83 Million USD | -6.85% |
| 2003 Q2 | 1.97 Million USD | 16.48% |
| 2002 Q3 | 2.31 Million USD | -35.28% |
| 2002 FY | 10.26 Million USD | 34.5% |
| 2002 Q2 | 3.57 Million USD | 35.8% |
| 2002 Q1 | 2.63 Million USD | 43.23% |
| 2002 Q4 | 1.73 Million USD | -25.05% |
| 2001 FY | 7.62 Million USD | -26.62% |
| 2001 Q3 | 1.79 Million USD | 17.11% |
| 2001 Q2 | 1.53 Million USD | -40.22% |
| 2001 Q1 | 2.56 Million USD | -0.89% |
| 2001 Q4 | 1.83 Million USD | 2.57% |
| 2000 Q1 | 2.39 Million USD | 26.16% |
| 2000 FY | 10.39 Million USD | 19.49% |
| 2000 Q4 | 2.58 Million USD | -2.01% |
| 2000 Q3 | 2.63 Million USD | -5.08% |
| 2000 Q2 | 2.77 Million USD | 15.89% |
| 1999 Q1 | 2 Million USD | 5.26% |
| 1999 Q3 | 2.1 Million USD | -16.0% |
| 1999 FY | 8.7 Million USD | 12.99% |
| 1999 Q4 | 1.9 Million USD | -9.52% |
| 1999 Q2 | 2.5 Million USD | 25.0% |
| 1998 FY | 7.7 Million USD | 6.94% |
| 1998 Q4 | 1.9 Million USD | -5.0% |
| 1998 Q3 | 2 Million USD | -13.04% |
| 1998 Q2 | 2.3 Million USD | 9.52% |
| 1998 Q1 | 2.1 Million USD | -19.23% |
| 1997 Q1 | 1.3 Million USD | 1.56% |
| 1997 FY | 7.2 Million USD | 89.47% |
| 1997 Q2 | 1.6 Million USD | 23.08% |
| 1997 Q3 | 1.6 Million USD | 0.0% |
| 1997 Q4 | 2.6 Million USD | 62.5% |
| 1996 FY | 3.8 Million USD | 92.89% |
| 1996 Q4 | 1.28 Million USD | 42.22% |
| 1996 Q3 | 900 Thousand USD | 21.62% |
| 1996 Q2 | 740 Thousand USD | 13.85% |
| 1996 Q1 | 650 Thousand USD | 0.0% |
| 1995 FY | 1.97 Million USD | 45.93% |
| 1994 FY | 1.35 Million USD | 8.87% |
| 1993 FY | 1.24 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -371.596% |
| IR-Med Inc. | 4.89 Million USD | 28.627% |
| Polarean Imaging plc | 12.24 Million USD | 71.468% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -164.522% |
| Avitar, Inc. | 3.56 Million USD | 2.144% |
| AVITA Medical, Inc. | 80.77 Million USD | 95.676% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -396.871% |
| Össur hf. | 396.18 Million USD | 99.118% |
| Zecotek Photonics Inc. | 3.46 Million USD | -0.912% |
| QHSLab, Inc. | 961.65 Thousand USD | -263.229% |
| Wellstar International, Inc. | 1.79 Million USD | -94.629% |
| Össur hf. | 396.18 Million USD | 99.118% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 83.961% |
| Escalon Medical Corp. | 5.25 Million USD | 33.475% |
| Aurora Spine Corporation | 8.65 Million USD | 59.653% |
| BrainsWay Ltd. | 28.01 Million USD | 87.533% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 63.479% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 89.596% |
| Vivos Inc. | 2.78 Million USD | -25.327% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.667% |
| Kelyniam Global, Inc. | 2.27 Million USD | -53.522% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -244.171% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -702.067% |
| Nanomix Corporation | 8.36 Million USD | 58.256% |
| Theraclion SA | 7.43 Million USD | 53.05% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -169.818% |
| Positron Corporation | 1 Million USD | -246.774% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -12.299% |
| Lombard Medical, Inc. | 30.29 Million USD | 88.468% |
| ALR Technologies Inc. | 6.33 Million USD | 44.871% |
| Stratec SE | 46.32 Million USD | 92.459% |
| Vycor Medical, Inc. | 1.27 Million USD | -173.861% |
| Heart Tronics, Inc. | 14.46 Million USD | 75.844% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2798.13% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1592.189% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 75.316% |
| VMS Rehab Systems, Inc. | 63.63 USD | -5489448.955% |
| Ingen Technologies, Inc. | 1.88 Million USD | -85.579% |
| Odyssey Group International, Inc. | -14.26 Million USD | 124.493% |
| United American Healthcare Corporation | 59 Thousand USD | -5820.339% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -757.209% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -450.349% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -106.008% |
| Urologix, Inc. | 10.09 Million USD | 65.388% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -176.491% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 41.277% |
| SS Innovations International, Inc. | 21.38 Million USD | 83.664% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1417.106% |
| Smith & Nephew plc | 3.46 Billion USD | 99.899% |
| NIOX Group Plc | 22.27 Million USD | 84.321% |
| Fuse Medical, Inc. | 10.35 Million USD | 66.251% |
| Broncus Holding Corporation | 38.15 Million USD | 90.844% |
| Brain Scientific Inc. | 9.66 Million USD | 63.851% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 66.097% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -5654.72% |